References
- Aure MR, Leivonen SK, Fleischer T, Zhu Q, Overgaard J, Alsner J, Tramm T, Louhimo R, Alnæs GI, Perala M, Busato F, Touleimat N, Tost J, Børresen-Dale AL, Hautaniemi S, Troyanskaya OG, Lingjærde OC, Sahlberg KK, Kristensen VN. Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors. Genome Biol 14, R126, 2013.10.1186/gb-2013-14-11-r126
- Bhattacharya S, Aggarwal R, Singh VP, Ramachandran S, Datta M. Downregulation of miRNAs during delayed wound healing in diabetes: Role of Dicer. Mol Med 2015.
- Chavali V, Tyagi SC, Mishra PK. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/− Akita hearts. Cell Biochem Biophys 68, 25–35, 2014.10.1007/s12013-013-9679-4
- Di Leva G, Calin GA, Croce CM. MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today 78, 180–189, 2006.
- Fardmanesh H, Shekari M, Movafagh A, Alizadeh Shargh S, Poursadegh Zonouzi AA, Shakerizadeh S, Poursadegh Zonouzi A, Hosseinzadeh A. Upregulation of the double-stranded RNA binding protein DGCR8 in invasive ductal breast carcinoma. Gene 581, 146–151, 2016.
- Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res 157, 253–264. 2011.
- Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol 9, 513–521, 2013.10.1038/nrendo.2013.8623629540
- Kalis M, Bolmeson C, Esguerra JL, Gupta S, Edlund A, Tormo-Badia N, Speidel D, Holmberg D, Mayans S, Khoo NK, Wendt A, Eliasson L, Cilio CM. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One 6, e29166, 2011.
- Kamali K, Korjan ES, Eftekhar E, Malekzadeh K, Soufi FG. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition. Bratisl Lek Listy 117, 376–380, 2016.
- Kantharidis P, Wang B, Carew RM, Lan HY. Diabetes complications: the microRNA perspective. Diabetes 60, 1832–1837, 2011.10.2337/db11-0082
- Kaspi H, Pasvolsky R, Hornstein E. Could microRNAs contribute to the maintenance of β cell identity? Trends Endocrinol Metab 25, 285–292, 2014.
- Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15, 321–333, 2015.10.1038/nrc393225998712
- McClelland AD, Kantharidis P. microRNA in the development of diabetic complications. Clin Sci (Lond) 126, 95–110, 2014.10.1042/CS20130079
- Melkman-Zehavi T, Oren R, Kredo-Russo S, Shapira T, Mandelbaum AD, Rivkin N, Nir T, Lennox KA, Behlke MA, Dor Y, Hornstein E. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J 30, 835–845, 2011.10.1038/emboj.2010.361
- Park SY, Jeong HJ, Yang WM, Lee W. Implications of microRNAs in the pathogenesis of diabetes. Arch Pharm Res 36, 154–166, 2013.2336158510.1007/s12272-013-0017-6
- Rahimi G, Jafari N, Khodabakhsh M, Shirzad Z, Dogaheh HP. Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus. Gynecol Endocrinol 31, 156–159, 2015.10.3109/09513590.2014.969700
- Tattikota SG, Sury MD, Rathjen T, Wessels HH, Pandey AK, You X, Becker C, Chen W, Selbach M, Poy MN. Argonaute2 regulates the pancreatic β-cell secretome. Mol Cell Proteomics 12, 1214–1225, 2013.2335850510.1074/mcp.M112.024786
- Poursadegh Zonouzi AA, Nejatizadeh A, Rahmati-Yamchi M, Fardmanesh H, Shakerizadeh S, Poursadegh Zonouzi A, Nejati-Koshki K, Shekari M. Dysregulated expression of Dicer in invasive ductal breast carcinoma. Med Oncol 32, 203, 2015.